Skip to menu Skip to content Skip to footer

2014

Journal Article

SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial

Rossi, Megan, Johnson, David W., Morrison, Mark, Pascoe, Elaine, Coombes, Jeff S., Forbes, Josephine M., McWhinney, Brett C., Ungerer, Jacobus P. J., Dimeski, Goce and Campbell, Katrina L. (2014). SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial. BMC Nephrology, 15 (1) 106, 106.1-106.10. doi: 10.1186/1471-2369-15-106

SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial

2014

Journal Article

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

Palmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Johnson, David W., Perkovic, Vlado, Hegbrant, Jorgen and Strippoli, Giovanni F.M. (2014). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, 2014 (5) CD007784. doi: 10.1002/14651858.CD007784.pub2

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

2014

Journal Article

Treatment for peritoneal dialysis-associated peritonitis

Ballinger, Angela E., Palmer, Suetonia C., Wiggins, Kathryn J., Craig, Jonathan C., Johnson, David W., Cross, Nicholas B. and Strippoli, Giovanni F.M. (2014). Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database of Systematic Reviews, 2014 (4) CD005284. doi: 10.1002/14651858.CD005284.pub3

Treatment for peritoneal dialysis-associated peritonitis

2014

Journal Article

A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients

Campbell, Katrina L., Johnson, David W., Bauer, Judith, Hawley, Carmel M., Isbel, Nicole M., Stowasser, Michael, Whitehead, Jonathan P., Dimeski, Goce and McMahon, Emma (2014). A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrology, 15 (1) 57, 57.1-57.6. doi: 10.1186/1471-2369-15-57

A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients

2014

Journal Article

The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis

Tang, Wen, Cho, Yeoungjee, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2014). The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 34 (2), 219-226. doi: 10.3747/pdi.2012.00318

The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis

2014

Journal Article

Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?

Cho, Yeoungjee and Johnson, David W. (2014). Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?. Current Opinion in Nephrology and Hypertension, 23 (2), 192-197. doi: 10.1097/01.mnh.0000441046.13912.1f

Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?

2014

Journal Article

Biocompatible dialysis fluids for peritoneal dialysis

Cho, Yeoungjee, Johnson, David W., Craig, Jonathan C., Strippoli, Giovanni F.M., Badve, Sunil V. and Wiggins, Kathryn J. (2014). Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database of Systematic Reviews, 2014 (3) CD007554. doi: 10.1002/14651858.CD007554.pub2

Biocompatible dialysis fluids for peritoneal dialysis

2014

Journal Article

Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis

Bose, Bhadran, Badve, Sunil V., Hiremath, Swapnil S., Boudville, Neil, Brown, Fiona G., Cass, Alan, De Zoysa, Janak R., Fassett, Robert G., Faull, Randall, Harris, David C., Hawley, Carmel M., Kanellis, John, Palmer, Suetonia C., Perkovic, Vlado, Pascoe, Elaine M., Rangan, Gopala K., Walker, Robert J., Walters, Giles and Johnson, David W. (2014). Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis. Nephrology Dialysis Transplantation, 29 (2), 406-413. doi: 10.1093/ndt/gft378

Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis

2014

Journal Article

Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies

Ruospo, Marinella, Palmer, Suetonia C., Craig, Jonathan C., Gentile, Giorgio, Johnson, David W., Ford, Pauline J., Tonelli, Marcello, Petruzzi, Massimo, De Benedittis, Michele and Strippoli, Giovanni F.M. (2014). Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrology Dialysis Transplantation, 29 (2), 364-375. doi: 10.1093/ndt/gft401

Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies

2014

Journal Article

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

Palmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Perkovic, Vlado, Johnson, David W., Nigwekar, Sagar U., Hegbrant, Jorgen and Strippoli, Giovanni F.M. (2014). HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database of Systematic Reviews, 2014 (1) CD005019, 1-64. doi: 10.1002/14651858.CD005019.pub4

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

2014

Journal Article

Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy

Morais, Christudas, Small, David M., Vesey, David A., Martin, Jennifer, Johnson, David W. and Gobe, Glenda C. (2014). Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy. Biochemical and Biophysical Research Communications, In Press, Corrected Proof (3), 1-6. doi: 10.1016/j.bbrc.2014.01.047

Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy

2014

Journal Article

Chronic kidney disease: Haemodialysis catheter care in practice

Badve, Sunil V. and Johnson, David W. (2014). Chronic kidney disease: Haemodialysis catheter care in practice. Nature Reviews Nephrology, 10 (3), 131-133. doi: 10.1038/nrneph.2014.3

Chronic kidney disease: Haemodialysis catheter care in practice

2014

Journal Article

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret, Topley, Nicholas and on behalf of the balANZ Trial Investigators (2014). Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrology, 15 (1) 8. doi: 10.1186/1471-2369-15-8

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

2014

Journal Article

Association between GFR estimated by multiple methods at dialysis commencement and patient survival

Wong M.G., Pollock C.A., Cooper B.A., Branley P., Collins J.F., Craig J.C., Kesselhut J., Luxton G., Pilmore A., Harris D.C. and Johnson D.W. (2014). Association between GFR estimated by multiple methods at dialysis commencement and patient survival. Clinical Journal of the American Society of Nephrology, 9 (1), 135-142. doi: 10.2215/CJN.02310213

Association between GFR estimated by multiple methods at dialysis commencement and patient survival

2014

Journal Article

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial

Johnson, David W., Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and for the HONEYPOT Study Collaborative Group (2014). Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial. The Lancet Infectious Diseases, 14 (1), 23-30. doi: 10.1016/S1473-3099(13)70258-5

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial

2014

Conference Publication

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

Rossi, M., Campbell, K. L., Johnson, D. W., Stanton, T., Pascoe, E. M., Hawley, C. M., Dimeski, G., Mcwhinney, B. C., Ungerer, J. P. and Isbel, N. M. (2014). Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. HOBOKEN: Wiley.

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

2014

Book Chapter

Erythropoiesis stimulating agent resistance

O'Shea, Stacey, Badve, Sunil V. and Johnson, David W. (2014). Erythropoiesis stimulating agent resistance. Advances in drug resistance research. (pp. 120-135) edited by Christudas Morais. New York, NY, United States: Nova Science Publishers.

Erythropoiesis stimulating agent resistance

2014

Conference Publication

Research priorities in chronic kidney disease: a priority setting partnership

Tong, A., Crowe, S., Chando, S., Cass, A., Chadban, S. J., Chapman, J. R., Gallagher, M., Gillis, J., Hawley, C., Hill, S., Howard, K., Johnson, D. W., Kerr, P., Mathew, T., Mckenzie, A., Parker, D., Polkinghorne, K., Perkovic, V., Pollock, C., Strippoli, G. F. M., Tugwell, P., Walker, R. G., Webster, A. C., Wilson, A., Wong, G. and Craig, J. C. (2014). Research priorities in chronic kidney disease: a priority setting partnership. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Research priorities in chronic kidney disease: a priority setting partnership

2014

Journal Article

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

Morrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014). Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 (1), 23-30. doi: 10.1038/ki.2013.391

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

2014

Conference Publication

Feasibility and construct validity of a frailty index for patients with chronic kidney disease

Smith, Morgan, Peel, Nancye, Dawson, Blake, Lambat, Zahed, Bak, Melissa, Johnson, David W. and Hubbard, Ruth E. (2014). Feasibility and construct validity of a frailty index for patients with chronic kidney disease. Australian and New Zealand Society for Geriatric Medicine Annual Scientific Meeting, Melbourne, VIC, Australia, 28–30 May 2014. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/ajag.12177

Feasibility and construct validity of a frailty index for patients with chronic kidney disease